Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Curevo Vaccine

Curevo Enrolls First Participants in Phase 2 Extension Trial
From Curevo Vaccine
Via GlobeNewswire
Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
From Curevo Vaccine
Via GlobeNewswire
Curevo Announces Positive Updated Phase 2 Data for Amezosvatein Shingles Vaccine
From Curevo Vaccine
Via GlobeNewswire
Curevo Vaccine to present at the 43rd Annual J.P. Morgan Healthcare Conference
From Curevo Vaccine
Via GlobeNewswire
Curevo Presents Positive Shingles Vaccine Outcomes Data
From Curevo Vaccine
Via GlobeNewswire
Curevo Vaccine Presents Amezosvatein Shingles Vaccine Data at ID Week
From Curevo Vaccine
Via GlobeNewswire
Dr. Chi Li Joins Curevo Vaccine as Chief Regulatory Officer
From Curevo Vaccine
Via GlobeNewswire
Curevo Vaccine Announces Positive Topline Results from Phase 2 Trial of Amezosvatein, a Next-Generation Vaccine for Shingles, Head-to-Head vs. Shingrix
From Curevo Vaccine
Via GlobeNewswire
Curevo Vaccine to present at the 42nd Annual J.P. Morgan Healthcare Conference
From Curevo Vaccine
Via GlobeNewswire
Guy De La Rosa, MD, Joins Curevo Vaccine as Chief Medical Officer
From Curevo Vaccine
Via GlobeNewswire
Curevo Vaccine Announces $26 Million Series A1 Financing to Support Clinical Development of Next-Generation Subunit Vaccines
From Curevo Vaccine
Via Business Wire
Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines
From Curevo Vaccine
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.